Brian T Hill

Brian T Hill

UNVERIFIED PROFILE

Are you Brian T Hill?   Register this Author

Register author
Brian T Hill

Brian T Hill

Publications by authors named "Brian T Hill"

Are you Brian T Hill?   Register this Author

79Publications

2268Reads

23Profile Views

The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.

Leuk Lymphoma 2019 Dec 19;60(12):2899-2908. Epub 2019 Jun 19.

Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1617858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858537PMC
December 2019

Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy.

Biol Blood Marrow Transplant 2019 Nov 4;25(11):e344-e351. Epub 2019 Jul 4.

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.036DOI Listing
November 2019

Descriptive comparison of hospital formulary decisions with published oncology valuation methods.

J Oncol Pharm Pract 2019 Oct 9:1078155219877927. Epub 2019 Oct 9.

Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Center, Cleveland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219877927DOI Listing
October 2019

Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma.

Bone Marrow Transplant 2019 Aug 30. Epub 2019 Aug 30.

Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0657-3DOI Listing
August 2019

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passé Yet?

Hemasphere 2019 Aug 7;3(4):e275. Epub 2019 Aug 7.

Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745924PMC
August 2019

The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.

Curr Oncol Rep 2019 Apr 2;21(5):44. Epub 2019 Apr 2.

Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Ave - CA6, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-019-0792-4
Publisher Site
http://dx.doi.org/10.1007/s11912-019-0792-4DOI Listing
April 2019

One Size Does Not Fit All: Who Benefits From Maintenance After Frontline Therapy for Follicular Lymphoma?

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:467-476. Epub 2019 May 17.

2 Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239065DOI Listing
January 2019

Cardiac Surgery Outcomes in Patients With Chronic Lymphocytic Leukemia.

Ann Thorac Surg 2018 04 15;105(4):1182-1191. Epub 2018 Feb 15.

Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.11.014DOI Listing
April 2018

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Leuk Lymphoma 2018 03 11;59(3):690-694. Epub 2017 Jul 11.

d Department of Internal Medicine, Division of Medical Oncology , University of Washington/Seattle Cancer Care Alliance , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1347932DOI Listing
March 2018

Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.

Clin Lymphoma Myeloma Leuk 2017 Dec 14;17(12):857-862. Epub 2017 Jul 14.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.07.003DOI Listing
December 2017

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.

Clin Lymphoma Myeloma Leuk 2017 Dec 13;17(12):797-803. Epub 2017 Jul 13.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.07.002DOI Listing
December 2017

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

N Engl J Med 2017 12 10;377(26):2531-2544. Epub 2017 Dec 10.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.S.N., J.R.W.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (F.L.L., J.C.C.); Washington University and Siteman Cancer Center, St. Louis (N.L.B., A. Ghobadi); University of Miami, Miami (L.J.L., K.V.K.); Stanford University, Stanford (D.B.M., R.L.), City of Hope National Medical Center, Duarte (T.S.), University of California at Los Angeles, Los Angeles (J.M.T.), University of California at San Diego, San Diego (J.E.C.), and Kite Pharma, Santa Monica (A.B., J.R., L.N., Y.J., J.A., M.E., D.C., J.W., W.Y.G.) - all in California; Dana-Farber Cancer Institute, Boston (C.A.J., E.D.J.); Montefiore Medical Center, Bronx (I.B.), and the University of Rochester School of Medicine, Rochester (J.W.F., P.R.) - both in New York; Vanderbilt University Medical Center (O.O.O.) and the Sarah Cannon Research Institute and Tennessee Oncology (I.W.F.), Nashville; Mayo Clinic, Rochester, MN (Y.L., T.E.W.); Loyola University Medical Center, Maywood, IL (P.J.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (A. Goy); Cleveland Clinic, Cleveland (B.T.H., M.R.S.); Karmanos Cancer Center, Wayne State University, Detroit (A.D.); University of Iowa Carver College of Medicine, Iowa City (U.F.); Colorado Blood Cancer Institute, Denver (P.M.S.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); and Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (I.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485PMC
December 2017

Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.

Br J Haematol 2017 11 13;179(4):674-676. Epub 2016 Jul 13.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14236DOI Listing
November 2017

Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.

Clin Pharmacokinet 2017 11;56(11):1255-1266

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-017-0529-1DOI Listing
November 2017

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Clinical approach to diffuse large B cell lymphoma.

Blood Rev 2016 11 30;30(6):477-491. Epub 2016 Jun 30.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2016.06.003DOI Listing
November 2016

Is rituximab sub-optimally dosed in indolent B cell lymphoma?

Br J Haematol 2016 09 2;174(5):721-9. Epub 2016 May 2.

Department of Medical Oncology and Hematology, Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14114DOI Listing
September 2016

It's Personal: Achieving Optimal Busulfan Exposure for All Patients.

Authors:
Brian T Hill

Biol Blood Marrow Transplant 2016 07 7;22(7):1149-1150. Epub 2016 May 7.

Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.024DOI Listing
July 2016

Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2016 06 16;22(6):1141-1144. Epub 2016 Mar 16.

Blood and Marrow Transplantation Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.011DOI Listing
June 2016

Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia.

Leuk Res 2016 Apr 21;43:9-12. Epub 2016 Feb 21.

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.02.008DOI Listing
April 2016

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas.

Blood Lymphat Cancer 2016;6:1-6. Epub 2016 Mar 15.

Department of Hematology, Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S73530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929980PMC
March 2016

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia.

Onco Targets Ther 2015 31;8:2391-7. Epub 2015 Aug 31.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://www.dovepress.com/profile-of-obinutuzumab-for-the-tre
Publisher Site
http://dx.doi.org/10.2147/OTT.S68770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562745PMC
September 2015

Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics.

Oncotarget 2015 Jul;6(19):16912-25

Department of Immunology, Lerner Research Institute, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627281PMC
http://dx.doi.org/10.18632/oncotarget.4857DOI Listing
July 2015

Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotin.

Leuk Lymphoma 2015 May;56(5):1552-3

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.911865DOI Listing
May 2015

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.

Am J Hematol 2015 Feb 19;90(2):144-8. Epub 2014 Nov 19.

Blood & Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23882DOI Listing
February 2015

Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment.

J Leuk (Los Angel) 2014 Dec;2(5)

Division of Hematology-Oncology, University Hospitals Case Medical Center, Cleveland, Ohio, USA ; Division of Hematology-Oncology, Case Western Reserve School of Medicine, Cleveland, USA ; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4172/2329-6917.1000160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431653PMC
December 2014

Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.

Blood 2014 Oct 17;124(17):2657-65. Epub 2014 Sep 17.

Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-02-558767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208281PMC
October 2014

Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Mol Cancer Res 2014 Sep 24;12(9):1205-15. Epub 2014 Jul 24.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163513PMC
September 2014

Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics.

Am J Clin Pathol 2014 Sep;142(3):339-46

From the R. Tomsich Pathology and Laboratory Medicine Institute and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPBWVHTF7RRSA4DOI Listing
September 2014

Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).

Br J Haematol 2014 Jan 17;164(2):297-9. Epub 2013 Oct 17.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12604
Publisher Site
http://dx.doi.org/10.1111/bjh.12604DOI Listing
January 2014

Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.

Leuk Lymphoma 2012 May 5;53(5):763-9. Epub 2012 Jan 5.

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.626882DOI Listing
May 2012

Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltration.

Leuk Lymphoma 2012 Apr 15;53(4):589-95. Epub 2011 Nov 15.

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2011.62
Publisher Site
http://dx.doi.org/10.3109/10428194.2011.623252DOI Listing
April 2012

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.

Br J Haematol 2011 Mar 12;152(5):561-9. Epub 2011 Jan 12.

Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2010.08549.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2010.08549.xDOI Listing
March 2011

Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.

Biol Blood Marrow Transplant 2010 Dec 14;16(12):1738-46. Epub 2010 Jun 14.

Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.06.009DOI Listing
December 2010

Acute myeloid leukemia: when to transplant in first complete remission.

Curr Hematol Malig Rep 2010 Apr;5(2):101-8

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-010-0042-1
Publisher Site
http://dx.doi.org/10.1007/s11899-010-0042-1DOI Listing
April 2010

Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.

J Pharm Sci 2007 Aug;96(8):2161-70

Merck and Co., Inc. Merck Manufacturing Division, West Point, Pennsylvania 19486, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002235491632315
Publisher Site
http://dx.doi.org/10.1002/jps.20866DOI Listing
August 2007

RNA-tethered phenyl azide photocrosslinking via a short-lived indiscriminant electrophile.

J Am Chem Soc 2003 Sep;125(36):10850-61

Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ja035743+DOI Listing
September 2003